Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in COGT — Cogent Biosciences, Inc.

CIK 1496201 TEL AVIV, L3

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,776,458
+$1,751,532 QoQ
Shares Held
459,340
+10.3% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#66
of 321 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Jun 30, 2025
CallValue
$1,436,000
CallShares
200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. COGT ranks #7 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 COGT
Cogent Biosciences, Inc.
This page
459,340 $17,776,458

All Filings in COGT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,776,458 459,340
2026-03-31 $16,024,926 416,340
2025-12-31 $13,444,320 378,500
2025-09-30 $1,414,833 98,526
2025-06-30 $1,436,000 200,000
2025-06-30 $1,031,715 143,693
2025-03-31 $2,006,793 335,024
2023-12-31 $1,524,101 259,201
2023-09-30 $4,095,000 420,000
2023-06-30 $4,972,800 420,000
2023-03-31 $3,237,000 300,000
2021-03-31 $6,695,355 762,569
2020-12-31 $8,258,923 735,434